{
  "PX2947B_syn_1": "Indication: RLL nodule + Adenopathy.\nEBUS: 4R(9mm) Pos, 7(11mm) Pos.\nENB: RLL 18mm nodule. rEBUS confirmed.\nSampling: TBNA x2, TBBx x3, Brush x2.\nResult: N2 disease + Primary sampled.",
  "PX2947B_syn_2": "OPERATIVE REPORT: Ms. [REDACTED] underwent combined staging and diagnostic bronchoscopy. EBUS-TBNA of stations 4R and 7 confirmed N2 nodal involvement (ROSE positive). Following this, electromagnetic navigation was used to localize an 18mm RLL lateral segment nodule. Tool-in-lesion was confirmed via radial EBUS. Transbronchial needle aspiration and forceps biopsies were obtained from the primary lesion.",
  "PX2947B_syn_3": "Codes: 31652 (EBUS 2 stations), 31629 (Peripheral TBNA), 31654 (rEBUS), 31627 (Nav).\nEBUS: 4R, 7.\nPeripheral: RLL mass (TBNA, Forceps, Brush).\nDiagnosis: Stage IIIB NSCLC.",
  "PX2947B_syn_4": "Resident Note\nPatient: [REDACTED]\nProcedure: Staging EBUS + ENB\n- Deep sedation.\n- EBUS: Sampled 4R and 7. Both malignant.\n- ENB: Navigated to RLL nodule.\n- Confirmed with rEBUS.\n- Took needle, forceps, and brush samples.\n- Bleeding controlled.",
  "PX2947B_syn_5": "sarah chen 67 female smoker rll mass and nodes. deep sedation propofol. did ebus first 4r and 7 both positive for cancer. then did navigation to the rll mass. radial ebus confirmed it. took 2 needle passes 3 biopsies and 2 brushes. moderate bleeding stopped with epi. discharged stable.",
  "PX2947B_syn_6": "Name: [REDACTED] | MRN# [REDACTED] | Birth: [REDACTED] Pre-procedure: 67yo former smoker with RLL peripheral nodule 18mm, no bronchus sign on CT. PET shows SUV 4.2. Anesthesia: Deep sedation - propofol infusion 75-100mcg/kg/min, Ramsay 4-5, BP q5min, SpO2 continuous Part 1 - EBUS staging for PET+ N2 nodes: Station 4R (9mm SA) - 4x passes, ROSE+, PET+ Station 7 (11mm SA) - 3x passes, ROSE+, PET+ Molecular testing sent from station 4R sample... [Rest of text]",
  "PX2947B_syn_7": "[Indication]\nRLL mass, mediastinal LAD.\n[Anesthesia]\nDeep Sedation.\n[Description]\nEBUS-TBNA of 4R and 7 (Both Positive). ENB to RLL mass. TBNA/TBBx/Brush performed. Bleeding controlled.\n[Plan]\nChemoradiation.",
  "PX2947B_syn_8": "We performed a two-part procedure for Ms. [REDACTED]. First, we used EBUS to check the lymph nodes in the center of her chest; stations 4R and 7 both showed cancer cells. Second, we used the navigation system to reach the main tumor in her right lower lung and took several biopsy samples. This confirms the cancer has spread to the lymph nodes (Stage IIIB), so we will discuss chemotherapy and radiation.",
  "PX2947B_syn_9": "Name: [REDACTED]. Chief Indication: RUL mass with mediastinal LAD. Procedure Performed: 1. EBUS-TBNA for staging. 2. Flexible bronchoscopy with endobronchial biopsy. EBUS Component: Systematic mediastinal evaluation. Station 4R: 5 passes, ROSE Positive. Station 7: 4 passes, ROSE Positive. Bronchoscopy Component: Examination revealed mass effect. Multiple forceps biopsies obtained. Assessment: N2/N3 disease verified.",
  "PX2947B": "Name: [REDACTED] | MRN# [REDACTED] | Birth: [REDACTED]\n\nPre-procedure: 67yo former smoker with RLL peripheral nodule 18mm, no bronchus sign on CT. PET shows SUV 4.2.\n\nAnesthesia: Deep sedation - propofol infusion 75-100mcg/kg/min, Ramsay 4-5, BP q5min, SpO2 continuous\n\nPart 1 - EBUS staging for PET+ N2 nodes:\nStation 4R (9mm SA) - 4x passes, ROSE+, PET+\nStation 7 (11mm SA) - 3x passes, ROSE+, PET+\nMolecular testing sent from station 4R sample\n\nPart 2 - Electromagnetic navigation bronchoscopy:\nTarget: RLL lateral segment 18mm nodule\nNavigation system registered, planning complete\nTool-in-lesion confirmed with radial EBUS - concentric pattern visualized\nFluoroscopy time: 4.2 minutes, DAP 156 cGy*cmÂ²\nSampling performed: needle aspirate x2, forceps biopsy x3, cytology brush x2\n\nSafety: Moderate bleeding from biopsy site controlled with topical epinephrine and blocker technique. Patient stable, no desaturation.\n\nPost-procedure: Patient recovered well, discharged after 2 hours observation."
}
